Cargando…

PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer

PURPOSE: Small-cell lung cancer (SCLC) is an aggressive high-grade neuroendocrine tumor with limited treatment strategies. Programmed death 1 (PD-1) and its ligand (PD-L1), delta-like ligand-3 (DLL-3), and poly ADP-ribose polymerase (PARP) inhibitors have shed light on the treatment of extensive sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Xiao, Liu, Zhiyan, Xiang, Luochengling, Liu, Mengjie, Zheng, Xiaoqiang, Wang, Jingjing, Liu, Na, Gao, Huan, Jiang, Aimin, Yang, Yujuan, Liang, Xuan, Ruan, Zhiping, Tian, Tao, Yao, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608588/ https://www.ncbi.nlm.nih.gov/pubmed/33154673 http://dx.doi.org/10.2147/CMAR.S260599

Ejemplares similares

Prognostic Nutritional Index identifies risk of early progression and survival outcomes in Advanced Non-small Cell Lung Cancer patients treated with PD-1 inhibitors
por: Liu, Na, et al.
Publicado: (2021)

The role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: Friend or foe?
por: Jiang, Aimin, et al.
Publicado: (2022)

Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study
por: Jiang, Aimin, et al.
Publicado: (2021)

Lipid metabolism-related gene prognostic index (LMRGPI) reveals distinct prognosis and treatment patterns for patients with early-stage pulmonary adenocarcinoma
por: Jiang, Aimin, et al.
Publicado: (2022)

The Construction and Analysis of Tumor-Infiltrating Immune Cells and ceRNA Networks in Bladder Cancer
por: Jiang, Aimin, et al.
Publicado: (2020)

Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma
por: Jiang, Aimin, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Solid Tumors: Real-World Incidence, Risk Factors, and Prognostic Analysis
por: Chen, Xue, et al.
Publicado: (2022)

PD-L2 based immune signature confers poor prognosis in HNSCC
por: Qiao, Yu, et al.
Publicado: (2021)

LINC00963 May Be Associated with a Poor Prognosis in Patients with Cervical Cancer
por: Chang, Aimin, et al.
Publicado: (2022)

Establishment and validation of a nomogram to predict the in-hospital death risk of nosocomial infections in cancer patients
por: Jiang, Aimin, et al.
Publicado: (2022)

PD-L1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of PD-1 and EBV-DNA load
por: Zhou, Yajuan, et al.
Publicado: (2017)

A novel risk classifier to predict the in-hospital death risk of nosocomial infections in elderly cancer patients
por: Jiang, Aimin, et al.
Publicado: (2023)

Efficacy Analysis of Adjuvant Chemotherapy with Gemcitabine Plus Platinum or S-1 in Biliary Tract Carcinoma: A Multi-Center Retrospective Study
por: Gao, Huan, et al.
Publicado: (2021)

Prognosis of limited-stage small cell lung cancer with comprehensive treatment including radical resection
por: Zhong, Lili, et al.
Publicado: (2020)

The pros and cons of the PCC staging system to guide surgical resectability and prognosis
por: Liu, Pei, et al.
Publicado: (2022)

HDAC10 Is Positively Associated With PD-L1 Expression and Poor Prognosis in Patients With NSCLC
por: Liu, Xiaomei, et al.
Publicado: (2020)

Elevated EXO1 expression is associated with breast carcinogenesis and poor prognosis
por: Liu, Jingjing, et al.
Publicado: (2021)

Association of PD-L1 and HIF-1α Coexpression with Poor Prognosis in Hepatocellular Carcinoma
por: Dai, Xiaomeng, et al.
Publicado: (2018)

Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Jung, Hae Il, et al.
Publicado: (2017)

Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancer
por: Yin, Feng, et al.
Publicado: (2020)

Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer
por: Qing, Yi, et al.
Publicado: (2015)

A Potential Biomarker of Combination of Tumor Mutation Burden and Copy Number Alteration for Efficacy of Immunotherapy in KRAS-Mutant Advanced Lung Adenocarcinoma
por: Xiang, Luochengling, et al.
Publicado: (2020)

Identification of key genes associated with poor prognosis and neoplasm staging in gastric cancer
por: Wang, Shuoshan, et al.
Publicado: (2023)

Dyskerin Overexpression in Human Hepatocellular Carcinoma Is Associated with Advanced Clinical Stage and Poor Patient Prognosis
por: Liu, Bei, et al.
Publicado: (2012)

Positive Phospho-Focal Adhesion Kinase in Gastric Cancer Associates With Poor Prognosis After Curative Resection
por: Peng, Ke, et al.
Publicado: (2022)

DSG2 expression is correlated with poor prognosis and promotes early-stage cervical cancer
por: Qin, Shuhang, et al.
Publicado: (2020)

Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma
por: Zeng, Zhen, et al.
Publicado: (2011)

Perioperative Serum Scoring Systems Predict Early Recurrence and Poor Prognosis of Resectable Pancreatic Cancer
por: Li, Shengnan, et al.
Publicado: (2022)

Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma
por: Fu, Tao, et al.
Publicado: (2016)

CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer
por: Nam, Yunha, et al.
Publicado: (2022)

The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma
por: Chen, Aifeng, et al.
Publicado: (2021)

LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
por: Luo, Yue, et al.
Publicado: (2021)

Simultaneous integrated dose reduction intensity-modulated radiotherapy applied to an elective nodal area of limited-stage small-cell lung cancer
por: LIU, ZHIYAN, et al.
Publicado: (2015)

Overexpression of AKR1B10 Predicts Poor Prognosis in Gastric Cancer Patients Undergoing Surgical Resection
por: Liu, Yu-Yin, et al.
Publicado: (2022)

Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma
por: Liu, Li-Li, et al.
Publicado: (2020)

High CTC-TRPC5 Expression Significantly Associated With Poor Prognosis in Radical Resected Colorectal Cancer Patients
por: Cai, Dongyan, et al.
Publicado: (2021)

Poorly differentiated thyroid carcinoma: a clinician’s perspective
por: Tong, Junyu, et al.
Publicado: (2022)

High GCLC level in tumor tissues is associated with poor prognosis of hepatocellular carcinoma after curative resection
por: Sun, Jialei, et al.
Publicado: (2019)

Higher platelet distribution width predicts poor prognosis in laryngeal cancer
por: Zhang, Huan, et al.
Publicado: (2017)

Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hk5mi5adv0542ajd7us0fm5hn2